In our diet-induced hyperinsulinaemic Rag1-/- mouse model [69], we investigated the effect of supraphysiological systemic UAG treatment (100μg/kg/day) on metabolic parameters and PC3 prostate cancer xenograft growth. The gene discussed is RAG1; the disease is prostate carcinoma.